AMLODIPINE BESYLATE
- Product NDC
- 43063-764
- 11-digit product format
- 430630764
- Labeler code
- 43063
- Product ID
- 43063-764_47d29cab-fc5f-977d-e063-6294a90a6bf1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- AMLODIPINE BESYLATE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA077073
- Marketing category
- ANDA
- Marketing start
- 2007-09-26
- Substance
- AMLODIPINE BESYLATE
- Active strength
- 2.5 mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- AMLODIPINE BESYLATE
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| AMLODIPINE BESYLATE | 2.5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 864V2Q084H |
| Rxcui | 308136 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 43063-764-30 | AMLODIPINE BESYLATE | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | | 16 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43063-764 | AMLODIPINE BESYLATE TABLET [PD-RX PHARMACEUTICALS, INC.] | 14 | Current NDC, Legacy NDC, 1 package rows | 20241016_e01efe66-2f31-4261-92ca-0b41f27104da.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43063-764-30 | 43063076430 | 30 TABLET in 1 BOTTLE, PLASTIC (43063-764-30) | 30 tablet | 2017-05-08 | 0000-00-00 | No | No | Current |